Results 61 to 70 of about 6,338,079 (289)

Line Probe Assay as a Rapid Tool for Detection of MDRTB

Annual Research & Review in Biology, 2014
Aims: To evaluate genotypic Line Probe Assay (LPA) for rapid detection of Multidrug Resistant Tuberculosis (MDRTB) directly from sputum samples in comparison with Drug Susceptibility Testing (DST) on phenotypic MBBacT liquid media. Study Design: Data analysis from 86 Mycobacterium tuberculosis (MTB) strains was done using SPSS version 17.
openaire   +1 more source

[Detection of rifampin-resistant Mycobacterium tuberculosis by line probe assay (LiPA)].

Kekkaku : [Tuberculosis], 2000
A recently described reverse hybridization-based line probe assay is used for the rapid detection of the mutations in the rpoB genes of rifampin-resistant Mycobacterium tuberculosis and for the identification of the M. tuberculosis complex. A multicenter study that included 5 laboratories was performed to evaluate the line probe assay in comparison ...
ABE, Chiyoji, OGATA, Hideo, KAWATA, Kanemitsu, HIRAGA, Toru, TAKASHIMA, Tetsuya, SUETAKE, Toshinori   +5 more
openaire   +2 more sources

Prevalence of drug resistance using line probe assay (LPA) results, conventional culture-based DST and combined among new and previously treated culture-positive TB cases.

, 2013
Prevalence of drug resistance using line probe assay (LPA) results, conventional culture-based DST and combined among new and previously treated culture-positive TB cases.
Eric Goemaere (129370), John Simpson (359843), Helen S. Cox (80991), David Coetzee (129367), Gerrit Coetzee (296078), Odelia Muller (359842), Gilles van Cutsem (93995), Cheryl McDermid (335960), Virginia Azevedo (335962), Marinus Barnard (359844)   +9 more
core   +1 more source

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba, Shweta Bansal, Tea Reljic, Allyne Montecillo‐Aguelo, Hamidah Alias, Farrah Amaranto, Maria Stella Aquino‐Calingasan, Bambang Ardianto, Eggi Arguni, Sally Blair, Thi Tam Dang, Maria Beatriz Gepte, Samanmalee Gunasekara, Andini Handayani, Miriam Kimpo, Catherine G. Lam, Nawachai Lertvivatpong, Sergio Licona, Ana Loseo, Ratha Mlis, Vivian Moreno Berrio, Nguyen Hoai Anh, Anna Lisa Ong‐Lim, Ha Thu Pham, Krishna Sagar Sharma, Bun Sereyleak, Sally Jane G. Velasco‐Aro, Su Yadana, Ambuj Kumar, Sheena Mukkada   +29 more
wiley   +1 more source

Multi-centre evaluation of the speed-oligo Mycobacteria assay for differentiation of Mycobacterium spp. in clinical isolates

BMC Infectious Diseases, 2011
Background A new DNA line probe assay (Speed-oligo Mycobacteria, Vircell) has been launched for rapid differentiation of Mycobacterium spp. from cultures.
Hofmann-Thiel Sabine, Turaev Laziz, Alnour Tarig, Drath Lore, Müllerova Maria, Hoffmann Harald   +5 more
doaj   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak, Katarzyna Bilska, Tomasz Koziński, Jadwiga Węcławek‐Tompol, Dorota Sega‐Pondel, Radosław Chaber, Wanda Badowska, Katarzyna Rosłan, Hanna Koseła‐Paterczyk, Anna Raciborska   +9 more
wiley   +1 more source

Reverse-hybridisation detection of CF mutations - a line-probe assay

, 1996
Australasian Biotechnology, Volume 6 Number 5, September/October 1996, pp.301-303 Reverse-hybridisation detection of CF mutations - a line- probe assay Karen Behm, Code Number: AU96017 Size of Files: Text: 8.6K Graphics: Line drawings (gif) - 3.4K ...

core   +1 more source

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda

BMC Infectious Diseases, 2010
Background About 500 new smear-positive Multidrug-resistant tuberculosis (MDR-TB) cases are estimated to occur per year in Uganda. In 2008 in Kampala, MDR-TB prevalence was reported as 1.0% and 12.3% in new and previously treated TB cases respectively ...
Haile Melles, Lukyamuzi George, Ademun Julius, Nyesiga Barnabas, Mukkada Sheena, Bwanga Freddie, Albert Heidi, Hoffner Sven, Joloba Moses, O'Brien Richard   +9 more
doaj   +1 more source

Characterization of Non-tuberculous Mycobacteria by Line Probe Assay Isolated from Pulmonary Tuberculosis Suspected Patients at Rajasthan

Journal of Pure and Applied Microbiology, 2022
Non-tuberculous Mycobacteria (NTM) are emerging as an important opportunistic pathogen. Since clinical presentation of NTM infection is similar to tuberculosis (TB), patients present as suspected TB or drug resistant TB.
Shreya Khandelwal, Bharti Malhotra, Widhi Dubey, Shipra Bhargava   +3 more
doaj   +1 more source

Line Probe Assay (LPA) testing and results among retreatment smear positive tuberculosis patients registered in three districts of Andhra Pradesh, India, April 2011 to March 2012.

, 2013
Line Probe Assay (LPA) testing and results among retreatment smear positive tuberculosis patients registered in three districts of Andhra Pradesh, India, April 2011 to March 2012.
Rani Samyukta (470068), Vishnu PH (340350), Dorai Deepa (470066), Koteswara Rao (470067), Mareli Claassens (396949), Ajay M. V. Kumar (295838), Jyoti Jaju (314884), Shanta Achanta (314883)   +7 more
core   +1 more source